Holding device, method of determining attraction abnormality in holding device, lithography apparatus, and method of manufacturing article
US-2024393682-A1 · Nov 28, 2024 · US
US9815921B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9815921-B2 |
| Application number | US-201213602616-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 4, 2012 |
| Priority date | Sep 1, 2011 |
| Publication date | Nov 14, 2017 |
| Grant date | Nov 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is directed to a construct for promoting absorption of molecules by a cell and the application thereof in drug and gene delivery. The present invention further describes topographical modulation of endocytosis for drug and gene delivery.
Opening claim text (preview).
The invention claimed is: 1. A construct for promoting absorption of molecules by a cell located at the surface of the construct; wherein the construct comprises: a plurality of protrusions located at the surface of the construct; wherein the protrusions are in the form of pillars having a diameter of between about 200 nm to about 2 μm; wherein the pitch between the protrusion from edge to edge is between 150 to 300 nm such that the pitch between the protrusions is less than the size of the cells to be located at the surface of the construct; wherein the protrusions have a size and are spaced apart from each other at a distance that promotes absorption of molecules by said cell and wherein the absorption of molecules is facilitated by endocytosis, or receptor mediated endocytosis, or pinocytosis, or phagocytosis; wherein the pillars are collapsed pillars lying at the surface of the construct; and wherein the collapsed pillars have a length of between about 50 nm to about 5 μm. 2. The construct of claim 1 , wherein the protrusions are arranged in an isotropic pattern. 3. The construct of claim 1 , wherein the protrusions are arranged in an anisotropic pattern. 4. The construct of claim 1 , wherein the protrusions are located at the surface of the construct in a detachable form. 5. The construct of claim 1 , wherein the protrusions are located at the surface of the construct in a non-detachable form. 6. The construct of claim 1 , wherein the protrusions are round. 7. The construct of claim 1 , wherein the protrusions are polygonal. 8. The construct of claim 1 , wherein the pillars are extend about 50 nm to 4 μm, or about 100 nm to about 2 μm above the surface of the construct. 9. The construct of claim 1 , wherein the pitch between the pillars from edge to edge is between 200 nm to 250 nm. 10. The construct of claim 1 , wherein a residual layer is arranged between the pillars and the surface of the construct. 11. The construct of claim 1 , wherein the construct is obtained via nano-imprinting lithography. 12. The construct of claim 11 , wherein the nano-imprinting lithography is thermal nano-imprinting lithography or UV nano-imprinting lithography. 13. The construct of claim 11 , wherein the construct and/or the protrusions are made of a polymer. 14. The construct of claim 13 , wherein the polymer is a synthetic polymer, or a rigid synthetic polymer, or a bioresorbable polymer, or a biodegradable polymer. 15. The construct of claim 14 , wherein the synthetic polymer is selected from the group consisting of poly(methyl methacrylate) (PMMA), polydimethylsiloxane (PDMS), polystyrene (PS) and mixtures thereof. 16. The construct of claim 15 , wherein the polystyrene is tissue-culture grade polystyrene (TCPS). 17. The construct of claim 14 , wherein the biodegradable polymer is selected from the group consisting of chitosan, poly(ε-caprolactone), polyglycolic acid, poly(lactic acid), polyphosphoester (PPE) and mixtures thereof. 18. The construct of claim 14 , wherein the rigid synthetic polymer is polystyrene. 19. The construct of claim 13 , wherein during manufacture the polymer is mixed with molecules which are to be absorbed by the cell to be located on the construct. 20. The construct of claim 13 , wherein the molecules are attached to the surface of the protrusions.
Continuous and nonuniform or irregular surface on layer or component [e.g., roofing, etc.] · CPC title
Lithographic processes using patterning methods other than those involving the exposure to radiation, e.g. by stamping · CPC title
Styrene · CPC title
General culture methods using substrates (for specific animal cell type C12N5/06) · CPC title
Synthetic polymers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.